NEWS

News
October 25 2026

Bestat Featured on the TV Program Key Search

Bestat Pharmaservices Corp. was recently featured on the television program Key Search, with the special segment airing on October 25 on MUCH TV Channel 38. Through on-site filming and interviews, the program offered viewers an inside look at Bestat and the professional role of a CRO, highlighting how the company leverages years of industry experience and multidisciplinary expertise to support biopharmaceutical products from development toward the market.

 

Bestat has long been dedicated to clinical research, providing professional services in clinical trial planning and execution, biostatistics, data management, and regulatory affairs. With multidisciplinary expertise spanning medicine, pharmacy, public health, and statistics, Bestat provides professional support throughout the biopharmaceutical development process.

 

As industry needs continue to evolve, Bestat has further integrated group resources and preclinical research capabilities, connecting preclinical studies and efficacy evaluation with clinical trials to build a more comprehensive, one-stop biopharma R&D service platform.

 

In response to the globalization of the biopharmaceutical industry, Bestat continues to expand its international presence. Building on years of project experience, professional data resources, and industry know-how, the company aims to strengthen its service capabilities and global competitiveness while supporting more biopharmaceutical products in reaching international markets.

 

The Key Search feature not only highlighted Bestat's expertise accumulated over years in the CRO industry, but also provided a closer look at the multidisciplinary talent, rigorous processes, and professional services behind the journey of new drugs and medical products from research and development to the market. Bestat will continue to build on its professional expertise while integrating technology, data, and industry experience to provide comprehensive support for biopharmaceutical R&D.

 

Bestat's continued commitment to clinical research and the biopharmaceutical industry also contributes to the United Nations Sustainable Development Goals (SDGs):

SDG 3 – Good Health and Well-Being

Supporting the development of medicines and medical products through preclinical research, clinical trials, and related professional services, thereby contributing to healthcare innovation and improved health and well-being.

SDG 9 – Industry, Innovation and Infrastructure

Integrating professional expertise, data, technology, and R&D resources to build a comprehensive biopharma R&D service platform while strengthening innovation and the global competitiveness of Taiwan's biotechnology industry.

 

Through this feature, we invite you to discover Bestat, learn more about the CRO industry, and explore the professional expertise behind biopharmaceutical research and development.

 

Watch the full Key Search – Bestat Pharmaservices Corp. feature:

https://www.youtube.com/watch?v=gKBnNB6MnYk

 

 

 

 

Bestat Pharmaservices Corp. was recently featured on the television program Key Search, with the special segment airing on October 25 on MUCH TV Channel 38. Through on-site filming and interviews, the program offered viewers an inside look at Bestat and the professional role of a CRO, highlighting how the company leverages years of industry experience and multidisciplinary expertise to support biopharmaceutical products from development toward the market.

 

Bestat has long been dedicated to clinical research, providing professional services in clinical trial planning and execution, biostatistics, data management, and regulatory affairs. With multidisciplinary expertise spanning medicine, pharmacy, public health, and statistics, Bestat provides professional support throughout the biopharmaceutical development process.

 

As industry needs continue to evolve, Bestat has further integrated group resources and preclinical research capabilities, connecting preclinical studies and efficacy evaluation with clinical trials to build a more comprehensive, one-stop biopharma R&D service platform.

 

In response to the globalization of the biopharmaceutical industry, Bestat continues to expand its international presence. Building on years of project experience, professional data resources, and industry know-how, the company aims to strengthen its service capabilities and global competitiveness while supporting more biopharmaceutical products in reaching international markets.

 

The Key Search feature not only highlighted Bestat's expertise accumulated over years in the CRO industry, but also provided a closer look at the multidisciplinary talent, rigorous processes, and professional services behind the journey of new drugs and medical products from research and development to the market. Bestat will continue to build on its professional expertise while integrating technology, data, and industry experience to provide comprehensive support for biopharmaceutical R&D.

 

Bestat's continued commitment to clinical research and the biopharmaceutical industry also contributes to the United Nations Sustainable Development Goals (SDGs):

SDG 3 – Good Health and Well-Being

Supporting the development of medicines and medical products through preclinical research, clinical trials, and related professional services, thereby contributing to healthcare innovation and improved health and well-being.

SDG 9 – Industry, Innovation and Infrastructure

Integrating professional expertise, data, technology, and R&D resources to build a comprehensive biopharma R&D service platform while strengthening innovation and the global competitiveness of Taiwan's biotechnology industry.

 

Through this feature, we invite you to discover Bestat, learn more about the CRO industry, and explore the professional expertise behind biopharmaceutical research and development.

 

Watch the full Key Search – Bestat Pharmaservices Corp. feature:

https://www.youtube.com/watch?v=gKBnNB6MnYk

 

 

 

 

Back
TOP